Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 13, 2024Nov 13 4:22 PMWELLS DAVID B
Proposed Sale
40,000$29.99$1.2M—

View →

Nov 12, 2024Nov 12 4:39 PMBoughton Soleil
Proposed Sale
2,338$26.46$61.9K—

View →

Nov 11, 2024Nov 12 1:52 PMCarroll Patrick Harrison
Proposed Sale
4,707$28.24$132.9K—

View →

Nov 11, 2024Nov 12 1:37 PMChi Michael
Proposed Sale
7,259$24.77$179.8K—

View →

Nov 5, 2024Nov 5 4:03 PMChi Michael
Proposed Sale
2,054$22.00$45.2K—

View →

Oct 29, 2024Oct 29 2:03 PMBoughton Soleil
Proposed Sale
2,339$23.16$54.2K—

View →

Oct 25, 2024Oct 25 6:00 PMChi Michael
Proposed Sale
17,304$22.00$380.7K—

View →

Oct 21, 2024Oct 21 2:59 PMChi Michael
Proposed Sale
7,500$22.20$166.5K—

View →

Oct 16, 2024Oct 16 1:58 PMBecklund Irene
Proposed Sale
471$22.64$10.7K—

View →

Oct 15, 2024Oct 15 8:19 PMChi Michael
Proposed Sale
75,493$22.00$1.7M—

View →

Oct 15, 2024Oct 15 3:43 PMBoughton Soleil
Proposed Sale
2,339$20.41$47.7K—

View →

Oct 7, 2024Oct 7 9:33 PMMelissa Baird
Proposed Sale
58,750$19.44$1.1M—

View →

Oct 1, 2024Oct 1 6:35 PMBoughton Soleil
Proposed Sale
2,339$18.50$43.3K—

View →

Sep 20, 2024Sep 20 8:34 PMAndrew Dudum
Proposed Sale
687,498$16.92$11.6M—

View →

Sep 17, 2024Sep 17 4:38 PMBoughton Soleil
Proposed Sale
2,339$16.50$38.6K—

View →

Sep 17, 2024Sep 17 2:59 PMBecklund Irene
Proposed Sale
10,017$16.50$165.3K—

View →

Sep 17, 2024Sep 17 2:57 PMChi Michael
Proposed Sale
25,550$16.50$421.6K—

View →

Sep 16, 2024Sep 16 2:53 PMBecklund Irene
Proposed Sale
472$16.45$7.8K—

View →

Sep 5, 2024Sep 5 9:22 PMMelissa Baird
Proposed Sale
11,749$14.43$169.5K—

View →

Sep 4, 2024Sep 4 10:27 PMMelissa Baird
Proposed Sale
11,749$14.61$171.7K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 22, 2026Sep 23 8:17 PMOluyemi OkupeChief Financial Officer
Option Exercise
14,000$5.0166,872(D)

View →

Aug 19, 2026Aug 20 8:30 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,938$5.0180,872(D)

View →

Aug 14, 2026Aug 18 9:04 PMSoleil BoughtonChief Legal Officer
Option Exercise
42,261—164,598(D)

View →

Aug 14, 2026Aug 18 9:04 PMKare SchultzDirector
Option Exercise
6,623—6,624(D)

View →

Aug 14, 2026Aug 18 9:04 PMPatrick Harrison CarrollChief Medical Officer
Option Exercise
26,187—131,678(D)

View →

Aug 14, 2026Aug 18 9:04 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
154,993—362,114(D)

View →

Aug 14, 2026Aug 18 9:04 PMMichael ChiChief Operating Officer
Option Exercise
86,265—329,194(D)

View →

Aug 17, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,388$5.0185,810(D)

View →

Aug 14, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
71,616—263,356(D)

View →

Aug 14, 2026Aug 18 9:04 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,920—427,953(D)

View →

Aug 14, 2026Aug 18 9:03 PMDavid B WellsDirector
Option Exercise
778—0(D)

View →

Aug 14, 2026Aug 18 9:03 PMMohamed ElshenawyCTO
Option Exercise
188,285—1,100,000(D)

View →

Aug 14, 2026Aug 18 9:03 PMIrene BecklundPAO
Option Exercise
13,685—54,317(D)

View →

Aug 14, 2026Aug 18 9:03 PMChristopher D PayneDirector
Option Exercise
545—0(D)

View →

Aug 12, 2026Aug 14 8:16 PMMohamed ElshenawyCTO
Grant/Award
1,200,000—1,200,000(D)

View →

Aug 12, 2026Aug 14 8:16 PMKare SchultzDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:16 PMChristopher D PayneDirector
Grant/Award
8,768—545(D)

View →

Aug 12, 2026Aug 14 8:15 PMGarcia Andrea G PerezDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMAnja ManuelDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMDelos M. CosgroveDirector
Grant/Award
8,223—8,223(D)

View →

Page 1 of 4

Next →